Investors & Media

Transformative science, targeted medicines

Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
8-K Report of unscheduled material events or corporate event View HTML
0001558370-16-010074.pdf
0001558370-16-010074.rtf
0001558370-16-010074.xls
8-K Report of unscheduled material events or corporate event View HTML
0001558370-16-009879.pdf
0001558370-16-009879.rtf
0001558370-16-009879.xls
10-Q Quarterly report which provides a continuing view of a company's financial position View HTML
0001558370-16-009951.pdf
0001558370-16-009951.rtf
0001558370-16-009951.xls
EX-101.INS - EX-101.INS
4 Statement of changes in beneficial ownership of securities View HTML
0001179110-16-031138.pdf
0001179110-16-031138.rtf
0001179110-16-031138.xls
SC 13G A statement of beneficial ownership of common stock by certain persons View HTML
0001193805-16-004164.pdf
0001193805-16-004164.rtf
0001193805-16-004164.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001179110-16-030755.pdf
0001179110-16-030755.rtf
0001179110-16-030755.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001179110-16-030355.pdf
0001179110-16-030355.rtf
0001179110-16-030355.xls
CT ORDER CT ORDER
9999999997-16-025877.pdf
3 Initial filing by director officer or owner of more than ten percent. View HTML
0001179110-16-029537.pdf
0001179110-16-029537.rtf
0001179110-16-029537.xls
8-K Report of unscheduled material events or corporate event View HTML
0001558370-16-008194.pdf
0001558370-16-008194.rtf
0001558370-16-008194.xls